Initial assessment for patients with HIV: Difference between revisions
From IDWiki
m (Aidan moved page RNA Human immunodeficiency virus HIV first clinic visit to First clinic visit for HIV without leaving a redirect) |
No edit summary |
||
| Line 1: | Line 1: | ||
| ⚫ | |||
= HIV: First clinic visit = |
|||
| ⚫ | |||
* Date and context of diagnosis |
* Date and context of diagnosis |
||
| Line 7: | Line 5: | ||
* Sexual history |
* Sexual history |
||
= Investigations = |
|||
* HIV-specific |
* HIV-specific |
||
| Line 24: | Line 22: | ||
** Urinalysis (glucose and protein) |
** Urinalysis (glucose and protein) |
||
= Initial regimens = |
|||
* All are integrase inhibitor with two nucleoside analogues |
* All are integrase inhibitor with two nucleoside analogues |
||
| Line 32: | Line 30: | ||
** Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine |
** Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine |
||
** Complera: emtricitabine/rilpivirine/tenofovir disoproxil |
** Complera: emtricitabine/rilpivirine/tenofovir disoproxil |
||
[[Category:HIV]] |
|||
Revision as of 23:44, 14 August 2019
History
- Date and context of diagnosis
- History of [HIV opportunistic infections](../Complications/Opportunistic infections/Opportunistic infections.md)
- Sexual history
Investigations
- HIV-specific
- CD4 count
- HIV-RNA viral load
- HLA B5701 genotyping (for abacavir)
- Genetic resistance assays
- G6PD deficiency
- STIs and coinfections
- Hepatitis A, B, and C serologies
- Syphilis
- Three-site mucosal (genital/rectal/throat) NAAT for chlamydia and gonorrhea
- Routine
- CBC, lytes, creatinine
- Fasting lipids
- Urinalysis (glucose and protein)
Initial regimens
- All are integrase inhibitor with two nucleoside analogues
- Consider one of the [HIV single-tablet regimens](Single-tablet regimens.md)
- Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
- Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
- Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
- Complera: emtricitabine/rilpivirine/tenofovir disoproxil
